
|Videos|August 30, 2018
Considering Triplet Therapy for Nondriver NSCLC
Considering Triplet Therapy for Nondriver NSCLC
Advertisement
A 64-Year-Old Woman With Metastatic NSCLC
- A 64-year-old woman reported having cough and shortness of breath on exertion for the past 2 years, but now having persistent symptoms even without exertion.
- PE: revealed diminished breath sounds and minimal expiratory wheezing in right lung; not physically fit
- PMH: mild hypertension well managed on lisinopril
- SH: smoker, 15 pack-years
- CT scan revealed 2 masses in RUL and several small masses in the liver
- Biopsy of right lung mass confirmed grade 2 adenocarcinoma
- EGFRnegative,KRASnegative
- IHC negative forALK-rearrangement,ROS1-rearrangement
- PD-L1 TPS: 56%
- PET scan showed multiple areas of FDG uptake in liver, SUVmax, 7.8
- Brain MRI, negative for metastases
- Diagnosis: stage IV lung adenocarcinoma
- Patient started on treatment with pembrolizumab/pemetrexed/carboplatin
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































